PUS3-related disorder: Report of a novel patient and delineation of the phenotypic spectrum

Am J Med Genet A. 2022 Feb;188(2):635-641. doi: 10.1002/ajmg.a.62547. Epub 2021 Oct 29.

Abstract

PUS3 encodes the pseudouridylate synthase 3, an enzyme catalyzing the formation of tRNA pseudouridine, which plays a critical role in tRNA structure, function, and stability. Biallelic pathogenic variants of PUS3 have been previously associated with severe intellectual disability, microcephaly, epilepsy, and short stature. We identified a novel homozygous PUS3 frameshift variant in a child with facial dysmorphisms, growth failure, microcephaly, retinal dystrophy, cerebellar hypoplasia, congenital heart defect, and right kidney hypoplasia. This patient further expands the phenotypic spectrum of PUS3-related disorders to include a more severe syndromic presentation.

Keywords: PUS3; congenital malformation; exome sequencing; tRNA.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • Developmental Disabilities / genetics
  • Homozygote
  • Humans
  • Intellectual Disability* / diagnosis
  • Intellectual Disability* / genetics
  • Intellectual Disability* / pathology
  • Microcephaly* / diagnosis
  • Microcephaly* / genetics
  • Nervous System Malformations*
  • Phenotype